VCYT Stock Analysis: Buy, Sell, or Hold?
VCYT - Veracyte, Inc.
$57.08
-2.77 (-4.63%)
▼
5d:
-2.51%
30d:
+19.41%
90d:
+76.17%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When VCYT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: VCYT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: VCYT shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$54.64
Based on 4.2% avg growth
INTRINSIC VALUE TODAY
$33.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCYT is currently trading at $57.08, which is considered extended relative to its 30-day fair value range of $44.48 to $53.53. From a valuation perspective, the stock is trading at a premium (Forward PE: 30.0) compared to its historical average (23.4). At these levels, the market is pricing in 8.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VCYT is in a strong uptrend. Immediate support is located at $51.92, while resistance sits at $60.91. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: VCYT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $49.10. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VCYT is in a strong uptrend. Immediate support is located at $51.92, while resistance sits at $60.91. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: VCYT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $49.10. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$44.48 -
$53.53
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
42.9%
All Signals
- BEARISH: Price extended above range (+6.6% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BEARISH: Trading 14.0% above Wall St target ($49.10)
- NEUTRAL: PE elevated vs history but 8.7% growth expectation is conservative given 289% recent growth
Trading Range Analysis
30-Day Trading Range
$44.48 -
$53.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$51.92
Resistance Level
$60.91
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.03
Wall Street Target
$49.10
(-14.0%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
288.9%
Profit Margin
16.2%
Valuation Premium vs History
+8.7% premium
PE vs Historical
30.0 vs 23.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.7%
(market-implied from PE analysis)
1-Year Target
$62.05
(+9%)
2-Year Target
$67.44
(+18%)
3-Year Target
$73.31
(+28%)
3-Yr Target (if PE normalizes)
(PE: 30→23)
PE COMPRESSION
$57.13
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.0, Growth: 4.4%)
$64.94
(+14%)
Base:
(SPY PE: 21.8, Growth: 4.4%)
$47.10
(-18%)
Bear:
(PE: 18.5, Growth: 4.4%)
$40.04
(-30%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Forward PE: 34.13 | Forward EPS (Implied): $1.67
Bull Case
$68.92
(+21%)
Analyst growth 15.0%, PE expands to 35.8
Base Case
$57.08
(0%)
Market implied 0.0%, PE stable at 34.1
Bear Case
$43.67
(-24%)
Severe decline -15.0%, PE contracts to 30.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 5:04 PM ET
Data refreshes hourly during market hours. Next update: 6:04 PM
Data refreshes hourly during market hours. Next update: 6:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCYT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
John Leite
SELL
5260 shares
2026-03-04
Marc Stapley
SELL
45523 shares
2026-03-04
Rebecca Chambers
SELL
18341 shares
2026-03-04
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
